Exploring High Growth Tech Stocks In The US Market April 2025

Simply Wall St.
Yesterday

Over the last 7 days, the United States market has dropped 5.6%, yet it has risen by 3.3% over the past year, with earnings expected to grow by 14% per annum in the coming years. In this fluctuating environment, identifying high growth tech stocks requires a focus on companies that demonstrate robust innovation and adaptability to capitalize on future opportunities.

Top 10 High Growth Tech Companies In The United States

Name Revenue Growth Earnings Growth Growth Rating
Super Micro Computer 20.44% 29.79% ★★★★★★
TG Therapeutics 26.03% 37.60% ★★★★★★
Alkami Technology 20.46% 85.16% ★★★★★★
Travere Therapeutics 28.45% 65.05% ★★★★★★
Clene 60.86% 63.07% ★★★★★★
AVITA Medical 27.91% 55.77% ★★★★★★
TKO Group Holdings 22.48% 25.17% ★★★★★★
Alnylam Pharmaceuticals 22.44% 58.55% ★★★★★★
Lumentum Holdings 21.61% 120.49% ★★★★★★
Ascendis Pharma 32.36% 59.79% ★★★★★★

Click here to see the full list of 237 stocks from our US High Growth Tech and AI Stocks screener.

We're going to check out a few of the best picks from our screener tool.

Heron Therapeutics

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on developing and commercializing therapeutics that enhance medical care, with a market capitalization of approximately $339.69 million.

Operations: Heron Therapeutics focuses on developing and commercializing therapeutic products, primarily generating revenue from its Drug Delivery Systems segment, which reported $144.29 million in revenue.

Heron Therapeutics, transitioning into profitability within the next three years, is demonstrating a robust trajectory with expected annual profit growth surpassing average market projections. Despite its current unprofitable status and a highly volatile share price, the company has significantly reduced its net loss to $13.58 million from $110.56 million year-over-year and anticipates revenue between $153 million and $163 million for 2025. This forward-looking guidance aligns with an annual revenue growth rate of 12%, outpacing the US market's average of 8.3%. Heron's strategic focus on enhancing operational efficiencies while expanding its market footprint could potentially reshape its financial landscape in the burgeoning biotech sector.

  • Get an in-depth perspective on Heron Therapeutics' performance by reading our health report here.
  • Understand Heron Therapeutics' track record by examining our Past report.

NasdaqCM:HRTX Earnings and Revenue Growth as at Apr 2025

Canaan

Simply Wall St Growth Rating: ★★★★★☆

Overview: Canaan Inc. focuses on the research, design, and sale of integrated circuits (IC) and leases mining equipment for bitcoin mining in China, with a market cap of approximately $334.82 million.

Operations: Canaan Inc. generates revenue primarily from its semiconductor segment, which contributed $269.32 million. The company is involved in the design and sale of integrated circuits for bitcoin mining operations in China.

Canaan's trajectory in the high-growth tech sector is underscored by its aggressive expansion into digital colocation and self-mining, marked by a recent agreement to deploy 17,453 ASICs with Mawson Infrastructure. This move not only boosts Canaan's operational capacity but also its strategic positioning within North America's competitive energy markets. Despite a net loss reduction to $249.75 million from $414.15 million year-over-year, Canaan forecasts robust revenue growth, expecting Q2 revenues between $120 million and $150 million. The firm’s R&D focus remains pivotal, aiming to enhance mining efficiency and drive future growth amidst market challenges.

  • Unlock comprehensive insights into our analysis of Canaan stock in this health report.
  • Explore historical data to track Canaan's performance over time in our Past section.

NasdaqGM:CAN Revenue and Expenses Breakdown as at Apr 2025

Gambling.com Group

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Gambling.com Group Limited is a performance marketing company serving the online gambling industry across North America, the United Kingdom, Ireland, Europe, and internationally with a market cap of $450.53 million.

Operations: The company generates revenue primarily through its Gambling Affiliation segment, which accounted for $127.18 million. As a performance marketing entity, it focuses on driving traffic and customer acquisition for online gambling operators across various regions.

Gambling.com Group has demonstrated robust financial performance with a notable 68% increase in earnings over the past year, significantly outpacing the media industry's growth of 26.4%. This surge is supported by an aggressive R&D strategy that not only fuels innovation but also enhances its competitive edge in the digital gambling sector. With a forecasted annual revenue growth of 17.5%, surpassing the US market average of 8.2%, and an expected return on equity at an impressive 46.2% in three years, Gambling.com is strategically positioned for sustained growth. Recent corporate actions, including a shelf registration for $8.68 million and a substantial credit facility expansion to $165 million, underscore its readiness to capitalize on emerging opportunities and bolster market presence.

  • Navigate through the intricacies of Gambling.com Group with our comprehensive health report here.
  • Evaluate Gambling.com Group's historical performance by accessing our past performance report.

NasdaqGM:GAMB Revenue and Expenses Breakdown as at Apr 2025

Key Takeaways

  • Reveal the 237 hidden gems among our US High Growth Tech and AI Stocks screener with a single click here.
  • Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
  • Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Searching for a Fresh Perspective?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
  • Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NasdaqCM:HRTX NasdaqGM:CAN and NasdaqGM:GAMB.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10